INT136630

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.42
First Reported 2006
Last Reported 2010
Negated 1
Speculated 0
Reported most in Abstract
Documents 3
Total Number 3
Disease Relevance 0.85
Pain Relevance 0.49

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

structural molecule activity (Gfap) extracellular matrix organization (Gfap) cytoplasm (Gfap)
Gfap (Rattus norvegicus)
Pain Link Frequency Relevance Heat
cerebral cortex 1 95.68 Very High Very High Very High
Spinal cord 7 92.32 High High
Glutamate 4 86.96 High High
Neuropathic pain 2 75.60 Quite High
ischemia 10 50.00 Quite Low
anesthesia 2 25.00 Low Low
bDMF 4 5.00 Very Low Very Low Very Low
isoflurane 3 5.00 Very Low Very Low Very Low
Hippocampus 3 5.00 Very Low Very Low Very Low
Central nervous system 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Infarction 9 97.88 Very High Very High Very High
Cretinism 2 77.72 Quite High
Neuropathic Pain 2 75.60 Quite High
Intellectual Impairment 1 74.60 Quite High
Thyroid Disease 2 72.24 Quite High
Brain Hemorrhage 2 50.00 Quite Low
Cv Unclassified Under Development 8 5.00 Very Low Very Low Very Low
Stroke 6 5.00 Very Low Very Low Very Low
Convulsion 3 5.00 Very Low Very Low Very Low
Middle Cerebral Artery Infarction 3 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The most marked changes in albumin and GFAP immunoreaction were seen after 2 weeks and persisted with mild intensities even after 10 weeks.
Regulation (changes) of GFAP Binding (immunoreaction) of
1) Confidence 0.42 Published 2006 Journal Pain Section Abstract Doc Link 16806707 Disease Relevance 0.08 Pain Relevance 0.32
Furthermore, the immunocontent of GFAP and NF subunits was down-regulated, while vimentin was unaltered both in tissue homogenate and in cytoskeletal fraction of hypothyroid animals.
Regulation (regulated) of GFAP Binding (immunocontent) of
2) Confidence 0.40 Published 2008 Journal Neurotoxicology Section Abstract Doc Link 18845185 Disease Relevance 0.30 Pain Relevance 0.17
In the penumbra, the immunoreactivity of NeuN and GFAP was unchanged after r-Hu-EPO treatment (Figs. 2B and C, I-R+EPO).
Neg (unchanged) Regulation (unchanged) of GFAP Binding (immunoreactivity) of
3) Confidence 0.26 Published 2010 Journal Anatomy & Cell Biology Section Body Doc Link PMC2998786 Disease Relevance 0.48 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox